Literature DB >> 34902458

Comparison of in-house SARS-CoV-2 genome extraction procedures. A need for COVID-19 pandemic.

Gabriel Martín1, Susana Rojo-Alba2, Cristian Castelló-Abietar2, Fátima Abreu-Salinas2, Isabel Costales2, Jose Antonio Boga2, Santiago Melón2, Marta Elena Álvarez-Argüelles2.   

Abstract

Among the methods used to diagnose COVID-19, those based on genomic detection by q(RT)-PCR are the most sensitive. To perform these assays, a previous genome extraction of the sample is required. The dramatic increase in the number of SARS-CoV-2 detection assays has increased the demand for extraction reagents hindering the supply of commercial reagents. Homemade reagents and procedures could be an alternative. Nasopharyngeal samples were extracted by seven different methods as well as the automatic method MagNaPure96, to detect SARS-CoV-2. All protocols show sensitivity higher than 87 %, in comparison with reference method, for detecting SARS-CoV-2 as well as human β- globin. Our results support that these procedures, using common and cheap reagents, are effective to extract RNA (from SARS-CoV-2) or DNA (from human β-globin) genome from nasopharyngeal swabs. Furthermore, these procedures could be easily adopted by routine diagnostic laboratories to implement detection methods to help to fight against COVID-19 pandemic.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COVID-19; Genome extraction; Heat extraction; In-house protocol; SARS-CoV-2

Mesh:

Substances:

Year:  2021        PMID: 34902458      PMCID: PMC8662953          DOI: 10.1016/j.jviromet.2021.114415

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


Introduction

In December 2019, Chinese health authorities identified the new betacoronavirus SARS-CoV-2 as the cause of the respiratory illness COVID-19, which was declared pandemic by World Health Organization in January 2020 (Wang et al., 2020; WHO, 2021). High sensitivity diagnostic methods to detect and contain potential outbreaks are required to fight against this pandemic. Among these methods, those based on genomic detection by quantitative retrotranscriptase (RT)-PCR have been proved to be the best for a quick and sensitive detection of COVID-19 infected patients. To perform these assays, a previous genome extraction of the sample is required. This step is essential since both quantity and quality of the genome obtained could affect the further amplification process (Rodríguez et al., 2020). Because of that, some studies comparing different commercial and/or manual procedures for genome extraction from different type of samples, such as fecal, blood or respiratory specimens have been reported (Verheyen et al., 2012; Mengelle et al., 2011; Yang et al., 2011). The current global health emergency due to SARS-CoV-2 pandemic has caused a dramatic increase in the number of detection assays performed by diagnostic laboratories and, therefore, a huge demand for extraction reagents making difficult the supply of commercial reagents. Homemade reagents and manual procedures are an alternative. Our team has conducted a comparative study between seven manual procedures with commercial and homemade reagents. The aim was to evaluate alternative protocols to commercial genome extraction procedures to be used for SARS-CoV-2 detection by routine diagnostic laboratories.

Material and methods

Samples

A total of 58 nasopharyngeal samples from patients with suspicious of SARS-CoV-2 infection were collected. The original volume of each sample (200 μL) was diluted 8 times to a final volume of 1.6 mL to get enough volume to perform all extraction procedures. From this final volume, 200 μL were used for each extraction procedure.

Genome extraction procedures

The automatic extraction method MagNa Pure 96 System (Roche, Ginebra, Switzerland), which is usually developed in the laboratory, was taken as reference. Seven different procedures were carried out manually. MagNA Pure 96 System and MagNA Pure 32 System (Roche) were performed using commercial reagents following manufacturer’s instructions. Other four protocols named as One-Step Method A (OSM-A), One-Step Method B (OSM-B), Two-Step Method (TSM) and “Bikop” method, were performed using common homemade reagents. For these protocols slight changes were established for the lysis reagents. For OSM-A and Bikop, lysis was made with guanidyl isocyanate (GIT), sarcosyl and sodium citrate, while for OSM-B it was made with GIT, SDS, Tris and EDTA. For TSM, first lysis step was made with SDS, Tris and EDTA and second lysis step was the same as for OSM-A and Bikop. Proteinase K (pK) was added in all lysis steps with GIT. For wash buffers, first was isopropanol, second was ethanol and third was a NaCl solution. All reagent concentrations and how were they used are specified on Table 1 .
Table 1

Extraction procedures steps.

StepsMagNa Pure 961(MP96)MagNa Pure 321(MP32)One-step method A(OSM-A)One-step method B(OSM-B)Two-steps method(TSM)"Bikop" methodHeat Extraction
1Lysis buffer MP96Incubate (10′- RT*)Lysis buffer MP32Incubate (10′- RT)Lysis buffer 12Incubate (10′- RT)Lysis buffer 13Incubate (10′- RT)Lysis buffer 14Incubate (10′- RT)Lysis buffer 12Incubate (10′- RT)Hot Spot (10′ - 95 °C)
2Lysis Buffer 22Incubate (10′ - RT)Freeze (5′ - 4 °C)
3Binding Buffer MP96Incubate in shaker(10′ – RT)Magnetize* &Remove SN*Binding Buffer MP32Incubate in shaker(10′ - RT)Magnetize &Remove SNBinding Buffer5Incubate in shaker(10′ - RT)Magnetize &Remove SNBinding Buffer5Incubate in shaker(10′ - RT)Magnetize &Remove SNBinding Buffer5Incubate in shaker(10′ - RT)Magnetize &Remove SNBinding Buffer5Incubate in shaker(10′ - RT)Magnetize &Remove SN
4Wash Buffer 1 MP96Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 1 MP32Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 16Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 16Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 16Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 16Incubate (10′ - RT)Magnetize &Remove SN
5Wash Buffer 2 MP96Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 2 MP32Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 27Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 27Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 27Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 27Incubate (10′ - RT)Magnetize &Remove SN
6Wash Buffer 3 MP96Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 3 MP32Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 38Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 38Incubate (10′ - RT)Magnetize &Remove SNWash Buffer 38Incubate (10′ - RT)Magnetize &Remove SN
7Elution Buffer MP96Magnetize &Collect SNElution Buffer MP32Magnetize &Collect SNElution Buffer9Magnetize &Collect SNElution Buffer9Magnetize &Collect SNElution Buffer9Magnetize &Collect SNElution Buffer 9Magnetize &Collect SN
Time (estimate)50′50′50′50′60′40′15′

*RT: Room Temperature.

*Using a 96R Ring Magnet Plate (Alpaqua, Beverly, MA).

*SN: supernatant.

Reagents and volumes suggested by manufacturer were used in these protocols.

Lysis Buffer 1: 200 μL GIT (GIT 4 M + sarcosyl 0,5% + sodium citrate 25 mM) and 10 μL pK (10 μg/μL).

Lysis Buffer 2: 200 μL GIT, 10 μL pK and 200 μL SDS (SDS 0,5% + Tris (pH 8) 10 mM + EDTA 1 mM).

Lysis Buffer 3: 200 μL SDS (SDS 0,5% + Tris (pH 8) 10 mM + EDTA 1 mM).

Binding Buffer: 200 μL magnetic beads in Isopropanol (1,5 g/mL), (Roche, Ginebra, Switzerland).

Wash Buffer 1: 200 μL isopropanol.

Wash Buffer 2: 200 μL EtOH.80 %.

Wash Buffer 3: 200 μL NaCl 0,5 M.

Elution Buffer: 100 μL water.

Extraction procedures steps. *RT: Room Temperature. *Using a 96R Ring Magnet Plate (Alpaqua, Beverly, MA). *SN: supernatant. Reagents and volumes suggested by manufacturer were used in these protocols. Lysis Buffer 1: 200 μL GIT (GIT 4 M + sarcosyl 0,5% + sodium citrate 25 mM) and 10 μL pK (10 μg/μL). Lysis Buffer 2: 200 μL GIT, 10 μL pK and 200 μL SDS (SDS 0,5% + Tris (pH 8) 10 mM + EDTA 1 mM). Lysis Buffer 3: 200 μL SDS (SDS 0,5% + Tris (pH 8) 10 mM + EDTA 1 mM). Binding Buffer: 200 μL magnetic beads in Isopropanol (1,5 g/mL), (Roche, Ginebra, Switzerland). Wash Buffer 1: 200 μL isopropanol. Wash Buffer 2: 200 μL EtOH.80 %. Wash Buffer 3: 200 μL NaCl 0,5 M. Elution Buffer: 100 μL water. The last protocol, which is based on heat treatment was performed in a SureCycler 8800 (Agilent Technologies, Santa Clara, CA) and no reagents were necessary. Protocols and reagents of the different genome extraction procedures were tested one time for each sample.

qRT-PCR

all extracted samples were tested with a multiple qRT-PCR directed to two regions of the SARS-CoV 2 genome (Orf1ab and N gene), as well as the human β- globin gen. Briefly, 5 μL of sample, previously extracted by any of the tested methods, were added to 10 μL of TaqMan Fast 1-Step Master Mix (Life technologies, Carlsbad, CA) supplemented with a mixture of primers (Thermo Fisher Scientific, Walthman, MA) and taqman MGB probes (Applied Biosystems, Foster City, CA) (Table 2 ). Amplification and subsequent analysis were carried out using the Applied Biosystems 7500 Real-time PCR System (Applied Biosystems). The cycling protocol was as follows: (50 °C, 20 min; 95 °C, 5 min; 45 cycles of 95 °C, 10 s; 55 °C, 15 s and 60 °C, 30 s).
Table 2

Primers and taqman MGB probes used to detect SARS-CoV2 and human β-globin.

DesignGenFunctionNameSequence (5′-3′)
In-houseORF1abForward primerCoV-2-OVI-SATCAAGTTAATGGTTACCCTAACATGT
SARS-CoV2Reverse primerCoV-2-OVI-AAACCTAGCTGTAAAGGTAAATTGGTACC
MGB FAM probeCoV-2-OVI-FAMCCGCGAAGAAGCTA
CDC1NForward primer2019-nCoV-N1-FGACCCCAAAATCAGCGAAAT
SARS-CoV2Reverse primer2019-nCoV-N1-RTCTGGTTACTGCCAGTTGAATCTG
MGB VIC probe2019-nCoV-N1-P-VICCCGCATTACGTTTGGT
In-houseβ-globinForward primerBeta-TR-SACACAACTGTGTTCACTAGC
HumanReverse primerBeta-TR-ACCAACTTCATCCACGTTCACC
MGB Cy5 probeBeta-Cy5TGCATCTGACTCCTGAGGA

Sequences published by Center for Disease Control and Prevention (CDC) (CDC, 2021).

Primers and taqman MGB probes used to detect SARS-CoV2 and human β-globin. Sequences published by Center for Disease Control and Prevention (CDC) (CDC, 2021).

Statistical studies

A T-Student test, whose null hypothesis was that in-house protocols works in the same way that the reference method, with a p-value of 0.05, was performed.

Results

Nasopharyngeal samples were extracted by seven different manual methods, as well as by the automatic extraction method MagNA Pure 96 used as reference, and amplified by qRT-PCR. According to the reference automatic method, β-globin gene was detected in all samples, being 30 of them also positive to SARS-CoV-2 genome. The cycle threshold (Ct) of each amplification and average, rank and 95 % CI of each method are shown in Table 3, Table 4 .
Table 3

Results of amplification of SARS-CoV-2 and human β-globin (Ct SARS-CoV-2/Ct β-globin).

SamplesMP96(automated)MP96(handmade)MP32OSM-AOSM-BTSM"Bikop" methodHeat Extraction
24 / 3630 / 4030 / 4031 / 4030 / 4029 / 4029 / 3631 / 38
24 / 2930 / 3330 / 3635 / 3431 / 3429 / 3627 / 3230 / 34
25 / 3429 / 3831 / 4031 / 3931 / 4032 / 3927 / 3527 / 38
26 / 3031 / 3431 / 3731 / 3933 / 3630 / 3430 / 3532 / 36
27 / 3131 / 3530 / 3732 / 4032 / 3531 / 3534 / 3633 / 40
27 / 2933 / 3432 / 3733 / 3634 / 3631 / 3531 / 3431 / 36
28 / 3933 / 4030 / 4032 / 4032 / 4031 / 4032 / 4030 / 40
30 / 2934 / 3133 / 3736 / 3532 / 3433 / 3531 / 3234 / 33
30 / 4031 / 3632 / 4031 / 4031 / 4030 / 4031 / 4032 / 40
10º31 / 3133 / 3833 / 3933 / 3434 / 3434 / 3634 / 3434 / 33
11°32 / 2933 / 3234 / 3534 / 3433 / 3633 / 3333 / 3333 / 40
12º32 / 3437 / 3934 / 3736 / 3935 / 3839 / 3737 / 3536 / 35
13º32 / 3334 / 3831 / 3433 / 4032 / 4032 / 3833 / 3934 / 40
14º32 / 3631 / 4032 / 3833 / 4032 / 4032 / 3832 / 4034 / 40
15º33 / 3733 / 4034 / 3739 / 4038 / 4033 / 4033 / 3834 / 40
16º33 / 3734 / 4033 / 4036 / 4036 / 400 / 4033 / 4034 / 40
17º33 / 2734 / 4033 / 3234 / 3535 / 3233 / 3533 / 310 / 34
18º33 / 3536 / 3835 / 4035 / 4035 / 4036 / 400 / 4037 / 40
19º0 (31)* / 3333 / 4034 / 400 / 3833 / 3734 / 3633 / 3634 / 35
20º33 / 3634 / 4034 / 4034 / 3733 / 4033 / 4033 / 4034 / 40
21°34 / 3434 / 3636 / 4037 / 3936 / 4034 / 3838 / 3836 / 40
22º34 / 3233 / 3533 / 400 / 3535 / 3733 / 3635 / 3535 / 34
23º34 / 2334 / 4034 / 3934 / 4034 / 4033 / 3733 / 4034 / 40
24º34 / 2837 / 3137 / 3334 / 3234 / 3234 / 3134 / 3035 / 28
25º34 / 4034 / 4034 / 4035 / 4036 / 4034 / 4035 / 4035 / 40
26º35 / 4036 / 4035 / 4037 / 4036 / 3935 / 4039 / 4038 / 40
27º35 / 3535 / 4036 / 4037 / 4037 / 4037 / 4037 / 3936 / 40
28º36 / 3834 / 4033 / 4034 / 4035 / 4035 / 4035 / 4035 / 40
29º0 (35)* / 2734 / 3033 / 3135 / 3135 / 3233 / 300 / 3238 / 31
30º0 (36)* / 330 / 033 / 3933 / 390 / 4035 / 3834 / 4035 / 38
31°- / 22- / 26- / 29- / 28- / 28- / 28- / 26- / 25
32º- / 23- / 0- / 35- / 33- / 31- / 33- / 32- / 33
33º- / 24- / 32- / 36- / 33- / 33- / 32- / 34- / 33
34º- / 25- / 33- / 37- / 34- / 34- / 34- / 35- / 33
35º- / 26- / 31- / 32- / 30- / 31- / 30- / 30- / 31
36º- / 27- / 32- / 35- / 31- / 32- / 32- / 34- / 32
37º- / 27- / 40- / 31- / 31- / 30- / 30- / 30- / 38
38º- / 28- / 32- / 40- / 33- / 34- / 33- / 35- / 34
39º- / 28- / 0- / 40- / 35- / 36- / 32- / 33- / 33
40º- / 28- / 0- / 36- / 32- / 33- / 32- / 35- / 33
41°- / 29- / 32- / 32- / 34- / 35- / 0- / 0- / 0
42º- / 29- / 0- / 40- / 33- / 33- / 35- / 34- / 37
43º- / 29- / 31- / 31- / 32- / 33- / 33- / 0- / 0
44º- / 29- / 33- / 34- / 33- / 33- / 34- / 33- / 32
45º- / 30- / 33- / 33- / 35- / 37- / 33- / 0- / 33
46º- / 30- / 36- / 38- / 34- / 33- / 38- / 35- / 0
47º- / 30- / 34- / 34- / 33- / 32- / 33- / 34- / 31
48º- / 31- / 35- / 35- / 39- / 37- / 35- / 0- / 32
49º- / 31- / 34- / 40- / 34- / 34- / 37- / 35- / 40
50º- / 31- / 33- / 33- / 36- / 36- / 35- / 0- / 0
51°- / 31- / 33- / 39- / 36- / 34- / 36- / 0- / 34
52º- / 32- / 37- / 37- / 33- / 34- / 35- / 33- / 32
53º- / 32- / 33- / 33- / 35- / 35- / 31- / 35- / 36
54º- / 32- / 35- / 35- / 40- / 0- / 35- / 35- / 38
55º- / 33- / 36- / 40- / 37- / 35- / 36- / 36- / 0
56º- / 34- / 38- / 38- / 37- / 0- / 0- / 0- / 37
57º- / 34- / 0- / 0- / 39- / 37- / 36- / 36- / 40
58º- / 34- / 0- / 35- / 39- / 37- / 33- / 35- / 0

these samples were negative on the MP96 automated extraction, so the Ct before dilution (in parenthesis) was used.

Table 4

Statistic data.

SARS CoV2 samplesMP96(automated)MP96(manual)MP32OSM-AOSM-BTSM"Bikop"methodHeat Extraction
Positives (sensitivity)30 (100 %)29 (96.7 %)30 (100 %)28 (93.3 %)29 (96.7 %)29 (96.7 %)28 (93.3 %)29 (96.7 %)
Mean ± σ31.43 ± 3.5433.27 ± 233 ± 1.8634.1 ± 2.0833.79 ± 2.0133.03 ± 2.2633.07 ± 2.8533.82 ± 2.44
Rank[24–36][29–37][30–37][31–39][30–38][29–39][27–39][27–38]
95 % IC[30.16–32.7][32.55–33.99][32.34–33.66][33.36–34.84][33.07–34.51][32.22–33.84][32.05–34.09][32.95–34.69]
Mean difference11.841.572.672.361.591.642.39
p-value0.03< 0.0010.040.010.060.270.01

Difference between means of the manual and automatic methods.

Results of amplification of SARS-CoV-2 and human β-globin (Ct SARS-CoV-2/Ct β-globin). these samples were negative on the MP96 automated extraction, so the Ct before dilution (in parenthesis) was used. Statistic data. Difference between means of the manual and automatic methods. The sensitivity for SARS-CoV-2 detection of the manual methods was calculated by comparison to automatic method. For OSM-A sensitivity was 93.3 % while for MP32 achieved 100 %. The limits of 95 % CI were 30.16 and 32.7 in automatic method MP96. By mean difference, in MP32 were 32.34 and 33.66 and in OSM-A were 33.36 and 34.84. The sensitivity for β-globin detection of the manual methods was also calculated by comparison to automatic method. For “Bikop” extraction sensitivity was 87.9 % while for OSM-A reached 100 %. The limits of 95 % CI were 30.16 and 32.38 in automatic method MP96. By mean difference, in “Bikop” extraction they were 34.53 and 36.25 and in MP32 they were 35.96 and 37.58.

Discussion

The expansion of the outbreak of the new coronavirus SARS-CoV-2 and the global pandemic situation caused by its spread has provoked the need of a quick and efficient tool for diagnosis of viral disease. Genome amplification based on PCR has been raised as the best method and as important as the amplification process is the previous genome extraction step. In this process, the viral genome as well as cellular genome is purified. Both genomes are used to amplify and quantify the viral genome and the human gene β-globin, respectively. The ratio between the two values allows calculating a normalized viral load and determining the sample quality (Lescure et al., 2020; Gómez-Novo et al., 2018). Considering that the use of PCR commercial kits is very usual in most clinical laboratories, the supply of reagents during pandemic peak was a common problem. Trying to obtain a solution for future similar situations, several extraction genome procedures were tested with the idea of obtaining a method to be included in manual or even automatic diagnostic procedures used routinely in clinical laboratories. Similar methods were also developed by other authors (Yamada et al., 1990; Arruda and Hayden, 1993; He et al., 2017). In our study, the sensitivity for SARS-CoV-2 of the tested procedures was higher than 93 %. These results were also observed in β-globin gene amplification, were all methods bowed sensitivity higher than 87 %. According these data, any method has enough sensitivity and can be used routinely in a clinical laboratory. Data were a little bit worse when Cts of SARS-CoV-2 were compared with reference methods, Also, higher Cts were observed in β-globin detection. Because sensitivity was decreased in both targets (SARS-CoV-2 and β-globin), viral load was minimally underestimated, no more than 0.5 log considering that each 3 Cts means a difference in the viral load of 1 log. A possible explanation to these results is that manual processing is less precise and more prone to error than automatic methods using a robot. Automatization of these procedures can solve this situation. One limitation of the tested procedures can be that they are not quick enough. A possible alternative is cut time at least in half for washing steps. In preliminary studies in our laboratory changes in results were not observed. The main advantage is the use of common reagents making possible these procedures can be easily adapted by any other laboratory directly or changing the reagents for other with similar properties. Furthermore, these procedures could also be used for the extraction of RNA or DNA genome of other viruses. Heat extraction method, whose sensitivities for SARS-CoV-2 and β-globin were 96.7 % and 87.9 %, respectively, can be used for a quick screening of patients under suspicion of infection by SARS-CoV-2. Recent reports using a similar method support the viability of this technology to SARS-CoV-2 genome extraction (Merindol et al., 2020; Mancini et al., 2020). Considering that this is the quickest (only 15 min), cheapest and easiest (only need a thermoblock) protocol of all the tested procedures, it appears as a clear alternative to be implemented in small diagnostic laboratories, favoring a decentralization of SARS-CoV-2 diagnostic and desaturating central hospitals. In this method, Cts were similar than in others, and good enough for using when samples level is high. It should be noted that only 5 μL of sample were used, in this method, half, in proportion, of that used in the other procedures. That could be the answer to that sensitivity is a little bit lower. In summary, in-house procedures evaluated can substitute commercial techniques performing a successful SARS-CoV-2 genome extraction using common and cheap reagents. On the other hand, human genome can also be successfully extracted allowing the use of β-globin gene as sample quality control and for normalized viral load calculus. These procedures could be easily adopted by clinical laboratories and be used to extract human samples with suspect of any viral presence. It is worth to note that Heat extraction is a quick, cheap, and easy diagnostic method, which could be used in small diagnosis laboratories.

Author statement

Gabriel Martín: Investigation, Data Curation, Writting Susana Rojo-Alba: Investigation, Data Curation, Writting Cristian Castelló-Abiétar: Resources, Writting Fátima Abreu-Salinas: Resources, Writting Isabel Costales: Resources, Writing Jose Antonio Boga: Writting – review and editing Santiago Melón: Writting – review and editing Marta Elena Álvarez-Argüelles: Conceptualization, Writting – review and editing

Funding

This research was partially granted by ASCOL (Asturiana de Control Lechero).

Data availability

Data will be made available on request.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  12 in total

1.  Extraction of viral nucleic acids: comparison of five automated nucleic acid extraction platforms.

Authors:  Jens Verheyen; Rolf Kaiser; Michael Bozic; Monika Timmen-Wego; Barbara K Maier; Harald H Kessler
Journal:  J Clin Virol       Date:  2012-04-13       Impact factor: 3.168

2.  A new method for extracting DNA or RNA for polymerase chain reaction.

Authors:  O Yamada; T Matsumoto; M Nakashima; S Hagari; T Kamahora; H Ueyama; Y Kishi; H Uemura; T Kurimura
Journal:  J Virol Methods       Date:  1990-02       Impact factor: 2.014

3.  Comparison of 2 highly automated nucleic acid extraction systems for quantitation of human cytomegalovirus in whole blood.

Authors:  Catherine Mengelle; Jean-Michel Mansuy; Isabelle Da Silva; Chistian Davrinche; Jacques Izopet
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

4.  Detection of human rhinovirus RNA in nasal washings by PCR.

Authors:  E Arruda; F G Hayden
Journal:  Mol Cell Probes       Date:  1993-10       Impact factor: 2.365

5.  Integrated DNA and RNA extraction using magnetic beads from viral pathogens causing acute respiratory infections.

Authors:  Hui He; Rongqun Li; Yi Chen; Ping Pan; Wenjuan Tong; Xueyan Dong; Yueming Chen; Daojun Yu
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

6.  Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing.

Authors:  Fabiola Mancini; Fabrizio Barbanti; Maria Scaturro; Giulia Errico; Angelo Iacobino; Antonino Bella; Flavia Riccardo; Giulia Marsili; Paola Stefanelli; Patrizio Pezzotti; Giovanni Rezza; Alessandra Ciervo
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

7.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

8.  SARS-CoV-2 detection by direct rRT-PCR without RNA extraction.

Authors:  Natacha Merindol; Geneviève Pépin; Caroline Marchand; Marylène Rheault; Christine Peterson; André Poirier; Claudia Houle; Hugo Germain; Alexis Danylo
Journal:  J Clin Virol       Date:  2020-05-07       Impact factor: 3.168

9.  Clinical and virological data of the first cases of COVID-19 in Europe: a case series.

Authors:  Francois-Xavier Lescure; Lila Bouadma; Duc Nguyen; Marion Parisey; Paul-Henri Wicky; Sylvie Behillil; Alexandre Gaymard; Maude Bouscambert-Duchamp; Flora Donati; Quentin Le Hingrat; Vincent Enouf; Nadhira Houhou-Fidouh; Martine Valette; Alexandra Mailles; Jean-Christophe Lucet; France Mentre; Xavier Duval; Diane Descamps; Denis Malvy; Jean-François Timsit; Bruno Lina; Sylvie van-der-Werf; Yazdan Yazdanpanah
Journal:  Lancet Infect Dis       Date:  2020-03-27       Impact factor: 25.071

10.  Comparison of procedures for RNA-extraction from peripheral blood mononuclear cells.

Authors:  Antonio Rodríguez; Hans Duyvejonck; Jonas D Van Belleghem; Tessa Gryp; Leen Van Simaey; Stefan Vermeulen; Els Van Mechelen; Mario Vaneechoutte
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.